¼¼°èÀÇ ¼Õ¹Ù´Ú Á¤¸Æ ¹ÙÀÌ¿À¸ÞÆ®¸¯½º ½ÃÀå
Palm Vein Biometrics
»óǰÄÚµå : 1571987
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2024³â 10¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 196 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,464,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 25,393,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼Õ¹Ù´Ú Á¤¸Æ ¹ÙÀÌ¿À¸ÞÆ®¸¯½º ½ÃÀåÀº 2030³â±îÁö 41¾ï ´Þ·¯¿¡ µµ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù.

2023³â¿¡ 11¾ï ´Þ·¯·Î ÃßÁ¤µÈ ¼Õ¹Ù´Ú Á¤¸Æ ¹ÙÀÌ¿À¸ÞÆ®¸¯½º ½ÃÀåÀº ¿¹Ãø ±â°£ µ¿¾È º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 20.3%·Î ¼ºÀåÇϰí, 2030³â¿¡´Â 41¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ BFSI ¿ëµµ´Â º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 20.8%·Î ¼ºÀåÀ» Áö¼ÓÇϰí, ºÐ¼® ±â°£ Á¾·á ½Ã 20¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±³À° ÀÀ¿ë ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ÀÇ º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)·Î 18.0%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 3¾ï 1,100¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç Áß±¹Àº º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 19.3%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¹Ì±¹ÀÇ ¼Õ¹Ù´Ú Á¤¸Æ ¹ÙÀÌ¿À¸ÞÆ®¸¯ ½ÃÀåÀº 2023³â 3¾ï 1,100¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº ¿¹Ãø ±â°£ µ¿¾È º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 19.3%·Î 2030³â±îÁö 6¾ï 2,150¸¸ ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. ´Ù¸¥ ÁÖ¸ñÇÒ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)Àº °¢°¢ 18.0%¿Í 16.9%·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) ¾à 13.7%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°è ¼Õ¹Ù´Ú Á¤¸Æ ¹ÙÀÌ¿À¸ÞÆ®¸¯½º ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ ¿ä¾à

¿Ö ¼Õ¹Ù´Ú Á¤¸Æ ¹ÙÀÌ¿À¸ÞÆ®¸¯½º°¡ ¼±È£µÇ´Â ÀÎÁõ ¹æ¹ýÀ¸·Î »ó½ÂÇϴ°¡?

¼Õ¹Ù´Ú Á¤¸Æ ¹ÙÀÌ¿À¸ÞÆ®¸¯½º´Â ±ÙÀû¿Ü¼±À» ÀÌ¿ëÇÏ¿© ¼ÕÀÇ Á¤¸Æ ÆÐÅÏÀ» Æ÷ÂøÇÏ´Â ºñÁ¢ÃË½Ä ÀÎÁõ ±â¼ú·Î, ¾ÈÀüÇÏ°í ½Å·Ú¼ºÀÌ ³ôÀº ¹ÙÀÌ¿À¸ÞÆ®¸¯½º ÀÎÁõ ¹æ¹ýÀ¸·Î¼­ ±Þ¼ÓÈ÷ º¸±ÞµÇ°í ÀÖ½À´Ï´Ù. ÀÌ ±â¼úÀº Á¤¹Ðµµ°¡ ³ô°í, À§Á¶¿¡ °­Çϰí, ºñħÀÔÇüÀÎ °ÍÀ¸·Î Æò°¡µÇ°í, º¸¾È°ú Æí¸®¼ºÀÌ ÃÖ¿ì¼±À¸·Î µÇ´Â ¿ëµµ¿¡ ÃÖÀûÀÔ´Ï´Ù. Áö¹®À̳ª ¾ó±¼ ÀÎÁõ°ú ´Þ¸® ¼Õ¹Ù´Ú Á¤¸Æ ÆÐÅÏÀº ÇǺΠ¾Æ·¡¿¡ Àֱ⠶§¹®¿¡ º¹Á¦¿Í º¯Á¶°¡ ¾î·Æ½À´Ï´Ù. ¼Õ¹Ù´Ú Á¤¸Æ ¹ÙÀÌ¿À¸ÞÆ®¸¯½º´Â ÀºÇà, ÇコÄɾî, Á¤ºÎ ¼­ºñ½º µî ¾ÈÀüÇÑ º»ÀÎ È®ÀÎÀÌ Áß¿äÇÑ ºÐ¾ß¿¡¼­ ä¿ëÀÌ ÁøÇàµÇ°í ÀÖ½À´Ï´Ù. ¼Õ¹Ù´Ú Á¤¸Æ ¹ÙÀÌ¿À¸ÞÆ®¸¯½º´Â ºñÁ¢Ã˽ÄÀ̱⠶§¹®¿¡ À§»ý¸é¿¡ ´ëÇÑ ¿ì·Á¿¡¼­ ÅÍÄ¡¸®½º ÀÎÁõ ½Ã½ºÅÛÀ¸·ÎÀÇ ÀüȯÀÌ ÁøÇàµÇ´Â À¯Çà ÀÌÈÄ ¼¼°è¿¡¼­´Â ƯÈ÷ ¸Å·ÂÀûÀÔ´Ï´Ù.

º¸¾È°ú ÇÁ¶óÀ̹ö½Ã¿¡ ´ëÇÑ ¿ì·Á´Â ¾î¶»°Ô ¼Õ¹Ù´Ú Á¤¸Æ ¹ÙÀÌ¿À¸ÞÆ®¸¯½º ¼ö¿ä¸¦ °ßÀÎÇϴ°¡?

»çÀ̹ö À§Çù°ú ID »ç±â°¡ Áõ°¡ÇÏ´Â ½Ã´ë¿¡ º¸¾È¿¡ ´ëÇÑ ¿ì·Á°¡ ¼Õ¹Ù´Ú Á¤¸Æ ¹ÙÀÌ¿À¸ÞÆ®¸¯½º äÅÃÀÇ Å« ¿øµ¿·ÂÀ̵Ǿú½À´Ï´Ù. ÀÌ ±â¼úÀº Áö¹® ÀÎÁõ ¹× ¾ó±¼ ÀÎÁõ°ú °°Àº ±âÁ¸ÀÇ ¹ÙÀÌ¿À¸ÞÆ®¸¯½º ½Ã½ºÅÛ¿¡ ºñÇØ ³ôÀº ¼öÁØÀÇ º¸¾ÈÀ» Á¦°øÇÕ´Ï´Ù. ¼Õ¹Ù´Ú Á¤¸Æ ¹ÙÀÌ¿À¸ÞÆ®¸¯½ºÀº ½±°Ô º¹Á¦ ÇÒ ¼ö¾ø´Â µ¶Æ¯ÇÑ ³»ºÎ ÆÐÅÏÀ» Á¦°øÇÏ¿© »ç±â¿Í ½ºÇªÇο¡ ´ëÇÑ °ß°íÇÑ º¸È£¸¦ º¸ÀåÇÕ´Ï´Ù. ¶ÇÇÑ, Áö¹®À̳ª ¾ó±¼ Ư¡°ú °°Àº ¿ÜºÎ Ư¡°ú ´Þ¸® ¾×¼¼½º ¹× º¹Á¦°¡ ¾î·Á¿î ¹ÙÀÌ¿À¸ÞÆ®¸¯½º µ¥ÀÌÅ͸¦ »ç¿ëÇÏ¿© °³ÀÎ Á¤º¸ º¸È£ ¹®Á¦¸¦ ÇØ°áÇÕ´Ï´Ù. ¼Õ¹Ù´Ú Á¤¸Æ ¹ÙÀÌ¿À¸ÞÆ®¸¯½º´Â ÀºÇà, ÇコÄɾî, Á¤ºÎ±â°ü µî µ¥ÀÌÅÍ º¸¾ÈÀÌ Áß¿ä½ÃµÇ´Â ºÐ¾ß¿¡¼­ º»ÀÎ È®ÀÎ ¹× ¾×¼¼½º Á¦¾î¸¦ À§ÇÑ °íµµ·Î ¾ÈÀüÇÏ°í ½Å·ÚÇÒ ¼ö ÀÖ´Â ¼Ö·ç¼ÇÀ¸·Î ÀÎÁ¤¹Þ°í ÀÖ½À´Ï´Ù.

ÇコÄÉ¾î ¾÷°è´Â ¾î¶»°Ô ¼Õ¹Ù´Ú Á¤¸Æ »ýüÀνÄÀÇ Ã¤ÅÃÀ» ¼±µµÇϰí Àִ°¡?

ÀÇ·á »ê¾÷Àº ¾ÈÀüÇϰí Á¤È®ÇÑ ºñÁ¢ÃË½Ä È¯ÀÚ ½Äº° ½Ã½ºÅÛ¿¡ ´ëÇÑ ¿ä±¸·ÎºÎÅÍ ¼Õ¹Ù´Ú Á¤¸Æ ¹ÙÀÌ¿À¸ÞÆ®¸¯½ºÀÇ Ã¤ÅÃÀ» °ßÀÎÇØ ¿Ô½À´Ï´Ù. º´¿ø°ú ÀÇ·á ½Ã¼³Àº ¼Õ¹Ù´Ú Á¤¸Æ ½ºÄ³³Ê¸¦ »ç¿ëÇÏ¿© ȯÀÚÀÇ ½Å¿øÀ» ÀÎÁõÇϰí ÀÇ·á ±â·ÏÀÌ ¿Ã¹Ù¸¥ °³Àΰú Á¤È®ÇÏ°Ô ¿¬°áµÇµµ·Ï ÇÏ°í ºÎÁ¤ û±¸¸¦ ¹æÁöÇÕ´Ï´Ù. ÀÌ ±â¼úÀº ¶ÇÇÑ À§»ýÀûÀÎ ºñÁ¢ÃË½Ä ¼Ö·ç¼ÇÀ» Á¦°øÇϸç, ƯÈ÷ COVID-19 ÆÒµ¥¹Í »óȲ¿¡¼­ ÀÓ»ó ȯ°æ¿¡¼­ °¨¿° ÀüÆÄÀÇ À§ÇèÀ» ¿ÏÈ­ÇÕ´Ï´Ù. ÇコÄɾ¼­ ¼Õ¹Ù´Ú Á¤¸Æ ¹ÙÀÌ¿À¸ÞÆ®¸¯½ºÀ» »ç¿ëÇϸé ȯÀÚÀÇ ¾ÈÀü¼ºÀ» ³ôÀÌ°í ¾÷¹« È¿À²¼ºÀ» Çâ»ó½Ã۰í HIPAA(ÀÇ·á º¸ÇèÀÇ »óÈ£ ¿î¿ë¼º ¹× Ã¥ÀÓ¿¡ °üÇÑ ¹ý·ü)¿Í °°Àº ¾ö°ÝÇÑ µ¥ÀÌÅÍ º¸È£ ±ÔÁ¤À» ÁؼöÇÕ´Ï´Ù. º¸ÀåÇÕ´Ï´Ù. ÀÇ·á½Ã¼³¿¡¼­´Â ȯÀÚ ±â·ÏÀÇ µðÁöÅÐÈ­°¡ ÁøÇàµÇ¾î ÀüÀÚ ÀÇ·á ½Ã½ºÅÛ¿¡ ´ëÇÑ ÀÇÁ¸µµ°¡ ³ô¾ÆÁö°í ÀÖÁö¸¸, ¼Õ¹Ù´Ú Á¤¸Æ ¹ÙÀÌ¿À¸ÞÆ®¸¯½º´Â ±â¹Ð¼ºÀÌ ³ôÀº ȯÀÚ µ¥ÀÌÅ͸¦ ¾ÈÀüÇÏ°Ô °ü¸®ÇÏ´Â ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù.

¼Õ¹Ù´Ú Á¤¸Æ ¹ÙÀÌ¿À¸ÞÆ®¸¯½º ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀº?

¼Õ¹Ù´Ú Á¤¸Æ ¹ÙÀÌ¿À¸ÞÆ®¸¯½º ½ÃÀåÀÇ ¼ºÀåÀº ¿©·¯ ¿äÀο¡ ÀÇÇØ ¹ß»ýÇÕ´Ï´Ù. ƯÈ÷ ÀºÇà, ÇコÄɾî, Á¤ºÎ±â°ü µîÀÇ ºÐ¾ß¿¡¼­ ¾ÈÀüÇÏ°í ºñÁ¢ÃËÀÎ ÀÎÁõ¹æ¹ý¿¡ ´ëÇÑ ¿ä±¸°¡ ³ô¾ÆÁö°í ÀÖ´Â °ÍÀÌ ¼Õ¹Ù´Ú Á¤¸Æ ¹ÙÀÌ¿À¸ÞÆ®¸¯½º ½Ã½ºÅÛ ¼ö¿ä¸¦ Å©°Ô ¹Ð¾î ¿Ã¸®°í ÀÖ½À´Ï´Ù. µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã¿¡ ´ëÇÑ °ü½É Áõ°¡¿Í »çÀ̹ö ¹üÁË Áõ°¡¿¡ Á÷¸éÇßÀ» ¶§ °ß°íÇÑ ID º¸È£ÀÇ Çʿ伺À¸·Î ÀÎÇØ ¼Õ¹Ù´Ú Á¤¸Æ ¹ÙÀÌ¿À¸ÞÆ®¸¯½ºÀº ¸Å·ÂÀûÀÎ ¼Ö·ç¼ÇÀ̵Ǿú½À´Ï´Ù. °Ô´Ù°¡, À¯ÇàÈÄÀÇ À§»ý°ú ¾ÈÀü¼º¿¡ ÁßÁ¡À» µÎ¾î ÅÍÄ¡¸®½º ±â¼ú·ÎÀÇ À̵¿ÀÌ °¡¼ÓÈ­µÇ°í ¼Õ¹Ù´Ú Á¤¸Æ ¹ÙÀÌ¿À¸ÞÆ®¸¯½ºÀÇ Ã¤¿ëÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¼¾¼­ ±â¼ú°ú ¹ÙÀÌ¿À¸ÞÆ®¸¯½º ¼ÒÇÁÆ®¿þ¾îÀÇ ±â¼úÀû Áøº¸µµ ¼Õ¹Ù´Ú Á¤¸Æ ½ºÄ³³ÊÀÇ Á¤È®¼º°ú ½Å·Ú¼ºÀ» Çâ»ó½ÃÄÑ ´Ù¾çÇÑ »ê¾÷¿¡¼­ÀÇ ÀÌ¿ëÀ» È®´ëÇϰí ÀÖ½À´Ï´Ù. ±â¾÷°ú ±â°üÀÌ º¸¾È°ú ÇÁ¶óÀ̹ö½Ã¸¦ ¼±È£ÇÏ´Â °¡¿îµ¥ ¼Õ¹Ù´Ú Á¤¸Æ ¹ÙÀÌ¿À¸ÞÆ®¸¯½º ½ÃÀåÀº Áö¼ÓÀûÀÎ ¼ºÀåÀ» ±â´ëÇϰí ÀÖ½À´Ï´Ù.

Á¶»ç ´ë»ó ±â¾÷ ¿¹(ÃÑ 46°Ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

BJH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Palm Vein Biometrics Market to Reach US$4.1 Billion by 2030

The global market for Palm Vein Biometrics estimated at US$1.1 Billion in the year 2023, is expected to reach US$4.1 Billion by 2030, growing at a CAGR of 20.3% over the analysis period 2023-2030. BFSI Application, one of the segments analyzed in the report, is expected to record a 20.8% CAGR and reach US$2.0 Billion by the end of the analysis period. Growth in the Education Application segment is estimated at 18.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$311.0 Million While China is Forecast to Grow at 19.3% CAGR

The Palm Vein Biometrics market in the U.S. is estimated at US$311.0 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$621.5 Million by the year 2030 trailing a CAGR of 19.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 18.0% and 16.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.7% CAGR.

Global Palm Vein Biometrics Market – Key Trends & Drivers Summarized

Why Is Palm Vein Biometrics Emerging as a Preferred Authentication Method?

Palm vein biometrics, a contactless identification technology that uses near-infrared light to capture the unique vein patterns in an individual's hand, is rapidly gaining traction as a secure and reliable biometric authentication method. This technology is valued for its high accuracy, resistance to forgery, and non-intrusive nature, making it ideal for applications where security and convenience are paramount. Unlike fingerprint or facial recognition, palm vein patterns are located beneath the skin, making them difficult to replicate or tamper with. Palm vein biometrics is being increasingly adopted in sectors such as banking, healthcare, and government services, where secure identity verification is crucial. The contactless nature of palm vein biometrics has made it particularly appealing in the post-pandemic world, where hygiene concerns are driving the shift toward touchless authentication systems.

How Are Security and Privacy Concerns Driving Demand for Palm Vein Biometrics?

In an era of increasing cyber threats and identity fraud, security concerns are a major driver behind the adoption of palm vein biometrics. This technology provides a higher level of security compared to traditional biometric systems like fingerprint or facial recognition, which can sometimes be spoofed or compromised. Palm vein biometrics offers a unique, internal pattern that is not easily replicated, ensuring robust protection against fraud and identity theft. Moreover, it addresses privacy concerns by using biometric data that is harder to access and reproduce, unlike external traits such as fingerprints or facial features. In sectors like banking, healthcare, and government, where data security is critical, palm vein biometrics is being recognized as a highly secure and reliable solution for identity verification and access control.

How Is the Healthcare Industry Leading the Adoption of Palm Vein Biometrics?

The healthcare industry has been a major driver in the adoption of palm vein biometrics due to its need for secure, accurate, and contactless patient identification systems. Hospitals and medical facilities are using palm vein scanners to authenticate patient identities, ensuring that medical records are accurately linked to the right individual and preventing fraudulent claims. This technology also offers a hygienic, contactless solution, reducing the risk of transmitting infections in clinical environments—a crucial consideration, especially in the context of the COVID-19 pandemic. The use of palm vein biometrics in healthcare enhances patient safety, improves operational efficiency, and ensures compliance with strict data protection regulations like HIPAA (Health Insurance Portability and Accountability Act). As healthcare facilities increasingly digitize patient records and rely on electronic health systems, palm vein biometrics offers a secure way to manage sensitive patient data.

What Is Driving Growth in the Palm Vein Biometrics Market?

The growth in the palm vein biometrics market is driven by several factors. The increasing need for secure and contactless authentication methods, particularly in sectors like banking, healthcare, and government, has significantly boosted demand for palm vein biometric systems. The growing focus on data privacy and the need for robust identity protection in the face of rising cybercrime have made palm vein biometrics an attractive solution. Additionally, the post-pandemic emphasis on hygiene and safety has accelerated the shift toward touchless technologies, further driving the adoption of palm vein biometrics. Technological advancements in sensor technology and biometric software have also improved the accuracy and reliability of palm vein scanners, expanding their use in various industries. As businesses and institutions continue to prioritize security and privacy, the palm vein biometrics market is expected to experience sustained growth.

Select Competitors (Total 46 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â